Clinical Trials Logo

Clinical Trial Summary

The study will identify the epidemiological and treatment profiles of acute peritonitis in Italy


Clinical Trial Description

The primary objectives of the study are: (1) the identification of specific risk factors for in-hospital mortality, in order to perfect the clinical management of patients with complicated intra-abdominal infections (cIAIs); (2) the identification of specific risk factors for multi-drug resistant organisms (MDROs) isolation in patients with cIAIs, in order to improve the adequacy of empirical antimicrobial therapy.

The secondary objectives are: (1) the description of the clinical, diagnostic and treatment profiles of patients with cIAIs in Italian surgical departments; (2) the analysis of epidemiology and patterns of antimicrobial susceptibility of the microorganisms isolated in samples in intra-operative samples of peritoneal fluid or purulent exudate/discrete abscesses in patients with cIAIs; (3) the identification of specific risk factors for post-operative complications in patients with cIAIs. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03678298
Study type Observational [Patient Registry]
Source World Society of Emergency Surgery
Contact Massimo Sartelli, MD
Phone 00393405369701
Email massimosartelli@gmail.com
Status Not yet recruiting
Phase
Start date January 1, 2019
Completion date April 1, 2020

See also
  Status Clinical Trial Phase
Completed NCT00389987 - Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037) Phase 3
Completed NCT02784704 - Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections Phase 3
Completed NCT01072539 - Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Completed NCT00752219 - Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections Phase 2
Completed NCT03830333 - Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015) Phase 3
Active, not recruiting NCT00860587 - Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections N/A
Completed NCT01844856 - Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections Phase 3
Completed NCT02475733 - Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs). Phase 2
Completed NCT00683332 - Post-Marketing Study Of The Safety Of Tygacil (Tigecycline) N/A